Posted inMarket
Canaccord Reaffirms Zscaler Stock Rating Amid Sales Force Transition
Canaccord Genuity maintains its current investment rating for Zscaler as the cloud security firm navigates a major sales force reorganization.
Posted inMarket
Legend Biotech Stock Maintained at Buy by H.C. Wainwright
H.C. Wainwright maintains its buy rating for Legend Biotech, highlighting strong market positioning and ongoing growth potential.
Posted inMarket
H.C. Wainwright Reaffirms Ionis Stock Rating Following Zanvastro Approval
H.C. Wainwright maintains its stock rating for Ionis Pharmaceuticals following the regulatory approval of Zanvastro, highlighting market confidence.
Posted inMarket
H.C. Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals Following Regulatory Nod in China
H.C. Wainwright maintains its Buy rating for Milestone Pharmaceuticals following a significant regulatory approval in China.
Posted inMarket
Why Stock Market Selloff Risks Are Growing and How Investors Should Respond
Discover why financial experts warn that stock market selloff risks are increasing and learn strategic steps to protect your investment portfolio today.
Posted inMarket
Why Government Market Interventions Are Alarming Global Investors
Discover why recent government market interventions like bond buybacks and currency buying are causing deep concern among global investors today.
Posted inMarket
Trading Strategy for Midterm Election Market Volatility
Discover how professional traders protect portfolios against potential market chaos and disputes during midterm elections using simple portfolio insurance.
Posted inMarket
Baird Raises DocuSign Stock Price Target Following Strong ARR Growth
Financial firm Baird has increased DocuSign stock price target to $72 following solid annual recurring revenue growth.
Posted inMarket
Freedom Broker Downgrades Vale Stock to Sell Amid Growth Concerns
Freedom Broker downgrades Vale stock rating to sell, citing high growth concentration risks and market challenges facing the mining giant.
Posted inMarket
Freeport-McMoRan Stock Upgraded by Freedom Broker Following Mine Recovery
Freedom Broker upgrades Freeport-McMoRan stock rating following the successful recovery of mining operations and steady market demand.
